Biocartis Group NV (BIOGF)
USD 0.66
(-85.33%)
USD 0.66
(-85.33%)
| Breakdown | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|
| Operating Cash Flow | -44.85 Million | -65.71 Million | -39.26 Million | -54.25 Million |
| Net Income | -65.38 Million | -71.47 Million | -62.93 Million | -64.06 Million |
| Depreciation & Amortization | 10.48 Million | 9.84 Million | 9.74 Million | 9.71 Million |
| Deferred income taxes | - | - | - | - |
| Stock-based compensation | 640 Thousand | 760 Thousand | 1.43 Million | 1.22 Million |
| Change in working capital | -3.85 Million | -9.64 Million | 3.32 Million | -4.49 Million |
| Other non-cash items | 17.61 Million | 8.24 Million | 15.68 Million | 7.97 Million |
| Investing Cash Flow | -5.43 Million | -3.74 Million | -4 Million | -5.49 Million |
| Investments in PPE | -1.93 Million | -3.75 Million | -3.02 Million | -2.51 Million |
| Acquisitions | -1 Million | - | -1 Million | -2.98 Million |
| Investment purchases | -2.5 Million | - | - | - |
| Sales/Maturities of investments | - | - | - | - |
| Other Investing Activities | -3862.00 | -62.00 | -1002.00 | -3375.00 |
| Financing Cash Flow | 22.46 Million | -1.2 Million | -11.52 Million | 175.02 Million |
| Debt repayment | -519 Thousand | -1.08 Million | -7.16 Million | -121.7 Million |
| Dividends payments | - | - | - | - |
| Common Stock Repurchased | - | - | - | - |
| Common Stock Issuance | 23.05 Million | - | - | 53.36 Million |
| Other Financing Activities | -73 Thousand | -115 Thousand | -4.35 Million | -37 Thousand |
| Accounts receivables | 1579.00 | -5916.00 | 1449.00 | -1182.00 |
| Accounts payables | - | - | - | - |
| Inventory | -5.29 Million | -2.73 Million | -4.04 Million | -3.85 Million |
| Other working capital | -139 Thousand | - | - | - |
| Cash at beginning of period | 53.52 Million | 123.66 Million | 178.72 Million | 63.53 Million |
| Cash at end of period | 26.12 Million | 53.52 Million | 123.66 Million | 178.72 Million |
| Capital Expenditure | -1.93 Million | -3.75 Million | -3.02 Million | -2.51 Million |
| Effect of forex changes on cash | 426 Thousand | 522 Thousand | -260 Thousand | -87 Thousand |
| Net cash flow / Change in cash | -27.39 Million | -70.14 Million | -55.05 Million | 115.18 Million |
| Free Cash Flow | -46.79 Million | -69.47 Million | -42.28 Million | -56.76 Million |
| Breakdown | 2023 Q2 | 2023 Q1 | 2022 FY | 2022 Q4 | 2022 Q3 | 2021 FY |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -15.62 Thousand | -15.62 Thousand | -65.38 Million | -18.3 Thousand | -18.3 Thousand | -71.47 Million |
| Depreciation & Amortization | 2595.00 | 2595.00 | 10.48 Million | 2553.50 | 2553.50 | 9.84 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | 171.00 | 171.00 | 640 Thousand | 144.00 | 144.00 | 760 Thousand |
| Change in working capital | -1428.50 | -1428.50 | -3.85 Million | -1619.50 | -1619.50 | -9.64 Million |
| Other non-cash items | -341.50 | -341.50 | 17.61 Million | 6878.50 | 6878.50 | 8.24 Million |
| Investing Cash Flow | -566.00 | -566.00 | -5.43 Million | -1918.50 | -1918.50 | -3.74 Million |
| Investments in PPE | -67.50 | -67.50 | -1.93 Million | -551.00 | -551.00 | -3.75 Million |
| Acquisitions | - | - | -1 Million | - | - | - |
| Investment purchases | - | - | -2.5 Million | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | -498.50 | -498.50 | -3862.00 | -1367.50 | -1367.50 | -62.00 |
| Financing Cash Flow | 14.84 Thousand | 14.84 Thousand | 22.46 Million | 16 Thousand | 16 Thousand | -1.2 Million |
| Debt repayment | - | - | -519 Thousand | - | - | -1.08 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | 23.05 Million | - | - | - |
| Other Financing Activities | 14.84 Thousand | 14.84 Thousand | -73 Thousand | 16 Thousand | 16 Thousand | -115 Thousand |
| Accounts receivables | -904.00 | -904.00 | 1579.00 | -1731.00 | -1731.00 | -5916.00 |
| Accounts payables | - | - | - | - | - | - |
| Inventory | -524.50 | -524.50 | -5.29 Million | 111.50 | 111.50 | -2.73 Million |
| Other working capital | - | - | - | - | - | - |
| Cash at beginning of period | - | - | 53.52 Million | - | 19.72 Thousand | 123.66 Million |
| Cash at end of period | -473.50 | -473.50 | 26.12 Million | 3200.00 | 22.92 Thousand | 53.52 Million |
| Capital Expenditure | -67.50 | -67.50 | -1.93 Million | -551.00 | -551.00 | -3.75 Million |
| Effect of forex changes on cash | -116.50 | -116.50 | 426 Thousand | -533.00 | -533.00 | 522 Thousand |
| Net cash flow / Change in cash | -473.50 | -473.50 | -27.39 Million | 3200.00 | 3200.00 | -70.14 Million |
| Free Cash Flow | -14.69 Thousand | -14.69 Thousand | -46.79 Million | -10.9 Thousand | -10.9 Thousand | -69.47 Million |
1023
RGXTF
CTS
000158
CCHBF
SO